(Q44087722)

29 November 2017

title

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension (English)

1 reference

29 November 2017

Myron H Weinberger

1

1 reference

29 November 2017

Barbara Roniker

series ordinal

2

1 reference

29 November 2017

Scott L Krause

series ordinal

3

1 reference

29 November 2017

Robert J Weiss

series ordinal

4

1 reference

29 November 2017

publication date

1 August 2002

1 reference

Journal of Clinical Hypertension

29 November 2017

published in

1 reference

29 November 2017

volume

15

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

709-716

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

Aldosterone and antialdosterone therapy in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

Efficacy and tolerance of spironolactone in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

The tissue effects of mineralocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902957-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0895-7061(02)02957-6

1 reference

29 November 2017

1 reference